Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |